Optogenetic therapy restores retinal activity in primate for at least a year following photoreceptor ablation.
McGregor JE, Kunala K, Xu Z, Murphy PJ, Godat T, Strazzeri JM, Bateman BA, Fischer WS, Parkins K, Chu CJ, Puthussery T, Williams DR, Merigan WH. Optogenetic therapy restores retinal activity in primate for at least a year following photoreceptor ablation. Mol Ther. 2022 03 02; 30(3):1315-1328.